# Xilio Therapeutics, Inc.: Form 8-K, filed Jan 8, 2026

- Company: [Xilio Therapeutics, Inc.](/companies/xlo.md) (CIK 1840233)
- Form: 8-K
- Filed: 2026-01-08
- Accepted by EDGAR: Jan 8, 2026, 08:42 ET
- Period: 2026-01-06
- Accession: 0001193125-26-007063
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1840233/000119312526007063/xlo-20260108.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1840233/000119312526007063/

## Items reported

- Item 2.02: Results of operations
- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1840233/000119312526007063/xlo-20260108.htm

Filed Jan 8, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-007063. Last ingested by Listed: Nov 15, 2026, 04:19 ET. No prices; not investment advice.
